Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01372462 · ClinicalTrials.gov registry record · NA

Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by Breathe Technologies.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01372462: Completed NA study of Chronic Obstructive Pulmonary Disease, sponsored by Breathe Technologies.

NCT01372462 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by Breathe Technologies. The registered enrollment target is 15 participants, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01372462, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by Breathe Technologies.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short term use of the Breathe Technologies noninvasive open ventilation (NIOV) system on respiratory mechanics during constant work rate exercise in subjects with severe COPD.

Primary Outcome

Mean differences between NIOV - oxygen, NIOV - Room Air, Nasal Cannula Oxygen, and no treatment (control).

Interventions

  • DEVICE NIOV - Room Air
  • DEVICE NIOV - Oxygen
  • DEVICE Nasal Cannula Oxygen

Study Locations (1)

California

  • Harbor-UCLA Medical Center - Torrance

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-07
Est. Completion 2012-05
Phase NA
Breathe Technologies

4 total trials

What the finished NCT01372462 record still lists

NCT01372462 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 3 interventions - of which NIOV - Room Air is the first listed.

NCT01372462 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01372462 about?

NCT01372462 is a clinical study titled "Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease". Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short term use of the Breathe Technologies noninvasive open ventilation (NIOV) system on respiratory mechanics during constant work rate exercise in subjects with...

What is the current status of trial NCT01372462?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-07. Estimated completion is 2012-05.

What conditions does trial NCT01372462 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT01372462?

The interventions under investigation include: NIOV - Room Air (DEVICE), NIOV - Oxygen (DEVICE), Nasal Cannula Oxygen (DEVICE).

Who is sponsoring clinical trial NCT01372462?

This trial is sponsored by Breathe Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01372462 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01372462's enrollment target sits among peer trials

15 80th of 86 higher than 6 of 86 other Chronic Obstructive Pulmonary Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01372462, the US trial registry maintained by the National Library of Medicine. NCT01372462 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.